Business Context and Reporting Period
Company: Quantum Computing Inc. (QUBT)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2025
Business Overview: QCi develops quantum computing, reservoir computing, and remote sensing technologies using integrated photonics. The company operates as a single reporting segment and is currently in a development stage with limited revenue, focusing on scaling its "Entropy Quantum Computer" (EQC) and Thin Film Lithium Niobate (TFLN) chip manufacturing capabilities.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sept 30, 2025 | Nine Months Ended Sept 30, 2025 | Balance Sheet (Sept 30, 2025) |
|---|---|---|---|
| Total Revenue | $384 | $484 | - |
| Gross Profit | $126 | $165 | - |
| Gross Margin | 33% | 34% | - |
| Net Income (Loss) | $2,382 | $(17,118) | - |
| Operating Loss | $(10,404) | $(28,861) | - |
| Cash & Cash Equivalents | - | - | $352,436 |
| Short-term Investments | - | - | $203,136 |
| Long-term Investments | - | - | $257,473 |
| Total Assets | - | - | $898,170 |
| Total Liabilities | - | - | $20,320 |
| Working Capital | - | - | $559,159 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 280% quarter-over-quarter (QoQ) to $384k and 56% year-over-year (YoY) for the nine months to $484k, driven by increased R&D services and cloud-based access to the Dirac-3 system.
- Profitability Shift: The company reported a net income of $2.4M for the quarter, reversing a net loss of $5.7M in the prior year quarter. This was primarily due to a $9.2M non-operating gain from the change in fair value of derivative liabilities (QPhoton warrants), offsetting an operating loss of $10.4M.
- Expense Expansion: Operating expenses rose 93% QoQ to $10.5M, with R&D increasing 101% due to higher headcount and lab costs, and G&A increasing 84% due to legal fees and internal control implementation.
- Liquidity Surge: Cash and cash equivalents grew from $78.9M (Dec 31, 2024) to $352.4M (Sept 30, 2025). Total investments (short and long-term) reached $460.6M following significant equity raises.
Guidance, Outlook, Risks, and Unusual Items
- Capital Raises: The company raised approximately $756.5M in net proceeds during the nine months ended Sept 30, 2025, through three private placements (Jan, June, and Sept). A subsequent $750M placement closed in October 2025 (Subsequent Event).
- Unusual Items: The Q3 net income is non-recurring, driven by a $9.2M mark-to-market gain on warrant liabilities. Operating cash flow remains negative at $(19.3M) for the nine-month period.
- Liquidity Outlook: Management believes current cash and investments ($813M combined) are sufficient to meet obligations for at least the next 12 months.
- Legal Proceedings:
- BV Advisory: Settled breach and appraisal claims in July 2025 for $750k cash and 1.9M shares.
- Securities Class Action: Filed Feb 2025 alleging misrepresentations regarding customers and operations; motion to dismiss due Nov 14, 2025.
- Derivative Actions: Four shareholder derivative suits filed in 2025 alleging fiduciary breaches; currently stayed pending the class action resolution.
- Controls: Management concluded that disclosure controls and procedures were not effective as of September 30, 2025.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the 280% revenue growth and the mix of R&D services vs. product sales.
- Non-GAAP Adjustments: Assess the impact of the $9.2M warrant liability gain on the reported net income; the core business remains operationally loss-making.
- Capital Efficiency: Monitor the burn rate relative to the $813M cash position and the timeline for commercializing TFLN chips.
- Legal Exposure: Track the status of the securities class action and derivative suits, which allege material misrepresentations.
- Internal Controls: Review the remediation plan for the ineffective disclosure controls and procedures.